National Biz News

All Business Stories for You!


T-Medical Group Inc. Expansion Into European Cannabis Market

New York, NY, March 18, 2024 –T-Medical Group Inc. (T-Medical), a leading medical technology provider with a well-established presence in the cannabis industry through its ownership of Telaleaf Health GmbH ( &, a Berlin-based cannabis telemedicine company, today announced a strategic expansion into the burgeoning European cannabis market. This bold move positions T-Medical to capitalize on the immense growth potential alongside established cannabis companies currently allocating significant resources towards Europe

T-Medical Leverages Telaleaf’s Success to Fuel European Expansion

T-Medical’s expansion leverages the proven success of Telaleaf Health, a pioneer in cannabis-based telemedicine. Telaleaf’s established presence in Germany, a leader in the European cannabis market, provides T-Medical with a strong foundation for further growth. By capitalizing on Telaleaf’s experience and expertise, T-Medical is poised to become a major player in the rapidly evolving European cannabis landscape.

European Cannabis Market Poised for Explosive Growth

The European cannabis market is experiencing explosive growth, fueled by a combination of factors:

● Increasing patient demand: Medical professionals are recognizing the potential of cannabis for various medical conditions, leading to a rise in patient demand.
● Evolving regulatory frameworks: Several European countries are implementing or revising cannabis regulations, opening doors for market expansion.
● Growing societal acceptance: Public perception of cannabis is shifting towards acceptance, creating a more favorable environment for the industry.

T-Medical Embarks on Strategic Capital Raise in Europe

To capture a significant share of this rapidly growing market, T-Medical is strategically raising capital in Europe. Industry estimates suggest the European cannabis market could reach €35 billion annually, with Germany as the current front-runner due to its established regulatory framework and large patient base. The funds raised will be used for:

● Expansion into key European markets: T-Medical will focus on establishing a strong presence in countries with favorable regulatory environments and high patient demand.
● Acquisitions: The company will explore strategic acquisitions of complementary businesses to accelerate its growth and broaden its product and service offerings.
● Technology development: T-Medical will continue to invest in cutting-edge medical technology solutions specifically tailored to meet the evolving needs of the European cannabis market.

T-Medical’s Advantages Position it for Success

T-Medical is well-positioned to capitalize on the European cannabis market opportunity due to its unique advantages:

● First-mover advantage: By proactively raising funds and focusing on Europe, T-Medical can secure a significant market share before competition intensifies.
● Proven expertise: Telaleaf’s success in Germany demonstrates T-Medical’s understanding of the European cannabis market and its ability to navigate the regulatory landscape.
● Cutting-edge technology: T-Medical’s commitment to innovation ensures it can deliver the latest medical technology solutions to optimize patient care within the European cannabis industry.
● Seasoned leadership team: The company’s leadership boasts a proven track record of success and the deep expertise necessary to navigate the intricacies of the European medical cannabis landscape.


Your email address will not be published. Required fields are marked *